The Diagnostic Value of sTWEAK in Acute Ischemic Stroke

Comertpay E., VURAL S., Eroglu O., Badem N. D., Bilgili Y. K., Coskun F.

BALKAN MEDICAL JOURNAL, vol.37, no.6, pp.336-340, 2020 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 37 Issue: 6
  • Publication Date: 2020
  • Doi Number: 10.4274/balkanmedj.galenos.2020.2020.2.45
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus, Academic Search Premier, CAB Abstracts, CINAHL, EMBASE, MEDLINE, Veterinary Science Database, Directory of Open Access Journals, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.336-340
  • Keywords: Ischemic area volume, ischemic stroke, magnetic resonance imaging, sTWEAK, MULTIFUNCTIONAL CYTOKINE, TWEAK, MANAGEMENT, PERFUSION, PREDICT, HEALTH, FN14, MRI
  • Dokuz Eylül University Affiliated: No


Background: Considering the critical role of early diagnosis and management of acute ischemic stroke, biomarkers that can reliable assist in the diagnosis are still needed. These biomarkers should rapidly analyze, have high specificity for brain damage, and be available in the emergency settings for early diagnosis and exclusion of other conditions that mimic acute ischemic stroke. Soluble tumor necrosis factor-like weak inducer of apoptosis, a protein involved in the regulation of several biological functions, could be a potential acute ischemic stroke biomarker.